Indapta Therapeutics

📍 Seattle & Houston, United States👥 18 employees💰 Last funded Dec 2020
Biotechnology🌐 indapta.com
Website LinkedIn
Indaptas allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Indapta Therapeutics?
Indapta Therapeutics has 1 investors on record on gritt.io.
When did Indapta Therapeutics last raise funding?
The most recent investment in Indapta Therapeutics recorded on gritt.io was in December 2020.
What industry is Indapta Therapeutics in?
Indapta Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Indapta Therapeutics based?
Indapta Therapeutics is headquartered in Seattle & Houston, United States.